Michael Schell

Title: Michael Schell: Innovator in Colorectal Cancer Research

Introduction

Michael Schell is a notable inventor based in Temple Terrace, FL (US). He has made significant contributions to the field of cancer research, particularly in the area of colorectal cancer. His work focuses on developing gene expression signatures that can predict the recurrence of colorectal cancer in patients.

Latest Patents

Michael Schell holds a patent for a colorectal cancer recurrence gene expression signature. This patent discloses gene signatures that may be used to predict the recurrence of colorectal cancer in a human patient. These signatures are crucial for determining when to treat a patient with post-operative adjuvant chemotherapy, especially when a high risk of recurrence is predicted.

Career Highlights

Throughout his career, Michael Schell has worked with esteemed institutions such as the H. Lee Moffitt Cancer Center and Research Institute, Inc. and Gibbs Cancer Center & Research Institute. His experience in these organizations has allowed him to contribute significantly to cancer research and patient care.

Collaborations

One of his notable collaborators is Timothy J. Yeatman. Their partnership has likely enhanced the research and development of innovative solutions in cancer treatment.

Conclusion

Michael Schell's work in developing predictive gene signatures for colorectal cancer recurrence showcases his dedication to improving patient outcomes. His contributions to cancer research are invaluable and highlight the importance of innovation in medical science.